A specific role of CD133+/HPCs has been suggested in pulmonary vascular remodelling in patients with obstructive pulmonary disease (Asosingh et al, 2008) or idiopathic pulmonary arterial hypertension (Diez et al, 2007). This evidence concerns the gene PROM1 and idiopathic pulmonary arterial hypertension.